159 related articles for article (PubMed ID: 29773301)
1. Pap tests in the diagnosis of cervical cancer: Help or hinder?
Philp L; Jembere N; Wang L; Gao J; Maguire B; Kupets R
Gynecol Oncol; 2018 Jul; 150(1):61-66. PubMed ID: 29773301
[TBL] [Abstract][Full Text] [Related]
2. Risk factors of cervical cancer after a negative cytological diagnosis in Polish cervical cancer screening programme.
Macios A; Didkowska J; Wojciechowska U; Komerska K; Glińska P; Kamiński MF; Nowakowski A
Cancer Med; 2021 May; 10(10):3449-3460. PubMed ID: 33934537
[TBL] [Abstract][Full Text] [Related]
3. Glandular Lesions of the Cervix in Clinical Practice: A Cytology, Histology, and Human Papillomavirus Correlation Study From 2 Institutions.
Miller RA; Mody DR; Tams KC; Thrall MJ
Arch Pathol Lab Med; 2015 Nov; 139(11):1431-6. PubMed ID: 25951104
[TBL] [Abstract][Full Text] [Related]
4. Conventional Pap smear and liquid-based cytology as screening tools in low-resource settings in Latin America: experience of the Latin American screening study.
Longatto-Filho A; Maeda MY; Erzen M; Branca M; Roteli-Martins C; Naud P; Derchain SF; Hammes L; Matos J; Gontijo R; Sarian LO; Lima TP; Tatti S; Syrjänen S; Syrjänen K
Acta Cytol; 2005; 49(5):500-6. PubMed ID: 16334026
[TBL] [Abstract][Full Text] [Related]
5. History of high-risk HPV and Pap test results in a large cohort of patients with invasive cervical carcinoma: experience from the largest women's hospital in China.
Tao X; Griffith CC; Zhou X; Wang Z; Yan Y; Li Z; Zhao C
Cancer Cytopathol; 2015 Jul; 123(7):421-7. PubMed ID: 25955972
[TBL] [Abstract][Full Text] [Related]
6. How useful are cervical Pap smears in detecting endometrial carcinomas? A tertiary cancer center experience.
Mehta SP; Patel TS; Jana T; Samanta ST; Malvania R; Trivedi PP; Girdher S
Diagn Cytopathol; 2021 Jan; 49(1):127-131. PubMed ID: 32910561
[TBL] [Abstract][Full Text] [Related]
7. A study of Pap test history and histologically determined cervical cancer in NSW women, 1997-2003.
Morrell S; Taylor R; Wain G
J Med Screen; 2005; 12(4):190-6. PubMed ID: 16417696
[TBL] [Abstract][Full Text] [Related]
8. Screening frequency and histologic type influence the efficacy of cervical cancer screening: A nationwide cohort study.
Chiang YC; Chen YY; Hsieh SF; Chiang CJ; You SL; Cheng WF; Lai MS; Chen CA;
Taiwan J Obstet Gynecol; 2017 Aug; 56(4):442-448. PubMed ID: 28805598
[TBL] [Abstract][Full Text] [Related]
9. Is a liquid-based cytology more sensitive than a conventional Pap smear?
Sigurdsson K
Cytopathology; 2013 Aug; 24(4):254-63. PubMed ID: 23331613
[TBL] [Abstract][Full Text] [Related]
10. Cervical cancer screening for survivors diagnosed with cancer before age 25.
Tseng OL; Spinelli JJ; Dawes M; McBride ML
J Cancer Surviv; 2017 Jun; 11(3):410-419. PubMed ID: 28127670
[TBL] [Abstract][Full Text] [Related]
11. The evaluation of cervical cancer screening by combining speculoscopy with Papanicolaou smear examination in Taiwan.
Chang JI; Ou CH; Wu KM; Chen CC; Cheng KC
Zhonghua Yi Xue Za Zhi (Taipei); 2002 Sep; 65(9):430-4. PubMed ID: 12433029
[TBL] [Abstract][Full Text] [Related]
12. Utility of imprint cytology for early presumptive diagnosis in clinically suspicious cervical cancer.
Halder K; Chachra KL; Sodhani P; Gupta S
Acta Cytol; 2008; 52(3):286-93. PubMed ID: 18540291
[TBL] [Abstract][Full Text] [Related]
13. A Groundbreaking Work Which Laid the Foundation for Mass Screening in Cervical Cytology in Japan.
Osamura RY
Acta Cytol; 2017; 61(4-5):299-304. PubMed ID: 28693014
[TBL] [Abstract][Full Text] [Related]
14. Cervical Papanicolaou Smears in Hematopoietic Stem Cell Transplant Recipients: High Prevalence of Therapy-Related Atypia during the Acute Phase.
Yu SC; Huang HH; Li CC; Tang JL; Lee YH; Mao TL; Kuo KT; Lin CT; Liu JH; Ko BS; Yao M
Biol Blood Marrow Transplant; 2017 Aug; 23(8):1367-1373. PubMed ID: 28450182
[TBL] [Abstract][Full Text] [Related]
15. Does speculum lubricant affect liquid-based Papanicolaou test adequacy?
Lin SN; Taylor J; Alperstein S; Hoda R; Holcomb K
Cancer Cytopathol; 2014 Mar; 122(3):221-6. PubMed ID: 24254917
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of modified rapid economic acetic acid-based Papanicolaou stain.
Bhagat P; Susheilia S; Singh K; Sadhukhan S; Rajwanshi A; Dey P
Cytopathology; 2016 Dec; 27(6):452-455. PubMed ID: 27019215
[TBL] [Abstract][Full Text] [Related]
17. Criticism of the Pap Smear as a Diagnostic Tool in Cervical Cancer Screening.
Schneider V
Acta Cytol; 2017; 61(4-5):338-344. PubMed ID: 28693015
[TBL] [Abstract][Full Text] [Related]
18. Pap smears in women with endometrial carcinoma.
Gu M; Shi W; Barakat RR; Thaler HT; Saigo PE
Acta Cytol; 2001; 45(4):555-60. PubMed ID: 11480718
[TBL] [Abstract][Full Text] [Related]
19. Sociodemographic factors associated with cervical cancer screening coverage and follow-up of high grade abnormal results in a population-based cohort.
Elit L; Saskin R; Raut R; Elliott L; Murphy J; Marrett L
Gynecol Oncol; 2013 Jan; 128(1):95-100. PubMed ID: 23085459
[TBL] [Abstract][Full Text] [Related]
20. Screening History Among Women with Invasive Cervical Cancer in an Academic Medical Center: Will We Miss Cancers Following Updated Guidelines?
Nitschmann C; May T; Mirkovic J; Feldman S
J Womens Health (Larchmt); 2016 Aug; 25(8):826-31. PubMed ID: 26859535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
